UPDATE: Phibro Animal Health (PAHC) Tops Q4 EPS by 2c; Guides FY17 EPS Below Views

(Updated - August 29, 2016 4:42 PM EDT)

Phibro Animal Health (NASDAQ: PAHC) reported Q4 EPS of $0.40, $0.02 better than the analyst estimate of $0.38. Revenue for the quarter came in at $189.2 million versus the consensus estimate of $183.62 million.

Guidance:

Sees FY17 revenue of $750 - $770 million and adjusted EPS of $1.38 - $1.45. The consensus is at revenue of $768.4 million and EPS of $1.63.

For earnings history and earnings-related data on Phibro Animal Health (PAHC) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
• Teck Resources (TECK) Misses Q1 EPS by 15c; reaffirms FY guidance
• Sanofi jumps as Q1 key profit measure tops estimates; Citi reiterates Buy